Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

Gastrointestinal cancers are expected to double worldwide by 2050, with pancreatic and colorectal cancers driving the sharpest increases. The projections show the growing impact of lifestyle-related ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Many patients do not know they have the disease ...

Pancreatic cancer is the 12th most common cancer worldwide. In 2022, there were 510,992 new cases of pancreatic cancer, with ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or delivering the wrong diagnosis.

Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four ...

Some of the most dangerous cancers are the types that are hard to detect. As a result, they are often caught too late to treat. Some emerging technologies could change that in the future, with ...

At present, doctors often rely on a blood test called CA 19-9 to monitor pancreatic cancer. However, this test is not very reliable for early detection because levels usually rise only after the ...